384:HKEXChina Gas Holdings Limited Analysis

Technical outlook is decidedly bearish: the current price of 3,330 KRW sits below the 20‑day SMA (3,516), the 50‑day SMA (3,899) and the 200‑day SMA (4,693), the MACD line remains under its signal (‑220 vs ‑213) and the RSI hovers around 42, indicating limited upside momentum. Volume is on a downtrend and 30‑day volatility is extreme at nearly 65%, while beta is low at 0.37, suggesting the stock’s moves are driven more by company‑specific factors than market swings. The max drawdown of almost 70% underscores the price’s vulnerability.
Fundamentally, the company shows a mixed picture: revenue grew 15% year‑over‑year, yet operating margins are negative (‑3.68%) and EBITDA is deeply in the red, with operating cash flow and free cash flow both strongly negative. Debt levels are high (≈13.9 bn KRW) relative to equity, and the price‑to‑sales ratio of 15.45 signals that the market is pricing in significant growth expectations despite the lack of earnings. No dividend is paid, and regulatory risk is elevated for medical‑software products. Combined, these factors point to an overvalued stock with substantial downside risk.